BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 14, 2017
View Archived Issues
Nature Cell starts U.S. trials for Astrostem stem cell therapy for Alzheimer's disease
Read More
MDA grant supports Izumi's early stage development of IZ-10023 for ALS
Read More
Mouse model developed for the study of alpha-gal meat allergy
Read More
IL13RA1 as a new prognostic marker for invasive breast cancer
Read More
Major vault protein as a new marker to distinguish leiomyoma from leiomyosarcoma
Read More
Sunovion seeks FDA approval for Aptiom for pediatric partial-onset seizures
Read More
Kissei and Maruishi to collaborate on development and marketing of MR-13A9 in Japan
Read More
ViiV Healthcare UK presents novel HIV integrase inhibitors
Read More
Celgene designates development candidate from MTAP pathway program under Agios agreement
Read More
Pfizer patents IRAK-4 inhibitors
Read More
Phase Ib data warrant progression of Heat Biologics' trial of HS-110 with nivolumab in NSCLC
Read More
Sichuan Kelun Pharmaceutical Research Institute discovers dipeptidyl peptidase 4 inhibitors
Read More
Marker can indicate desensitization during immunotherapy for milk allergy
Read More
SBI enters into Japanese marketing agreement with Chugai for Alaglio
Read More
Portola Pharmaceuticals presents novel PCSK9 inhibitors
Read More
Pfizer launches Zavicefta in U.K. and Germany
Read More
FDA approves Kisqali for HR+/HER2- breast cancer
Read More
Phase III results confirm long-term safety of Indivior's RBP-7000 in schizophrenia
Read More
Charles River Laboratories and Chiesi extend respiratory drug discovery partnership
Read More
Phase III study of Repatha in patients with high LDL-C on apheresis meets endpoints
Read More
Stellar Biotechnologies and Matrivax sign technology transfer agreement for C. difficile technology
Read More
Myriad Genetics launches EndoPredict test in U.S. for breast cancer
Read More
Grants support reMYND's work in epilepsy and Alzheimer's disease
Read More
Toray Industries and Maruho sign worldwide agreement for RORgammat inhibitor
Read More
OncBioMune completes acquisition of Vitel Laboratorios
Read More
CRISPR Therapeutics and Casebia sign commercial license agreement with MaxCyte
Read More
Transcriptional coactivator YAP1 found to be expressed in high-grade endometrial carcinomas
Read More